Dysbiosis and Therapeutic Modulation of the Gut Microbiota in Multiple Sclerosis: A Narrative Review
Altering the gut microbiota in patients with MS may serve as a potentially effective treatment strategy. Nevertheless, future research should prioritize the standardization of these therapies. Finally, it is imperative that researchers concentrate on large-scale studies or trials to scrutinize the practical relevance of these therapeutic options.
Authors
- Mojtaba Memariani (ORCID: https://orcid.org/0000-0002-4964-3117)
- Hamed Memariani (ORCID: https://orcid.org/0000-0003-1026-140X)
Institutions
- Pasteur Institute of Iran (IR)
- Biotechnology Research Center (IR)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/hsr2.71564
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00